150 related articles for article (PubMed ID: 12535740)
21. Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults.
Janatuinen T; Laakso J; Laaksonen R; Vesalainen R; Nuutila P; Lehtimäki T; Raitakari OT; Knuuti J
Vasc Med; 2003; 8(3):185-9. PubMed ID: 14989559
[TBL] [Abstract][Full Text] [Related]
22. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
Böger RH; Bode-Böger SM
Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
[TBL] [Abstract][Full Text] [Related]
23. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus.
Mittermayer F; Pleiner J; Krzyzanowska K; Wiesinger GF; Francesconi M; Wolzt M
Wien Klin Wochenschr; 2005 Dec; 117(23-24):816-20. PubMed ID: 16437318
[TBL] [Abstract][Full Text] [Related]
24. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.
Marcovecchio ML; Widmer B; Dunger DB; Dalton RN
Clin Sci (Lond); 2008 Dec; 115(12):361-9. PubMed ID: 18498242
[TBL] [Abstract][Full Text] [Related]
25. Predictors of the intima-media thickness of carotid artery in asymptomatic newly detected severe hypercholesterolemic patients.
Vladimirova-Kitova L; Deneva T; Marinov B
Clin Physiol Funct Imaging; 2010 Jul; 30(4):250-9. PubMed ID: 20662876
[TBL] [Abstract][Full Text] [Related]
26. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
[TBL] [Abstract][Full Text] [Related]
27. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
[TBL] [Abstract][Full Text] [Related]
28. The levels of asymmetric dimethylarginine, homocysteine and carotid intima-media thickness in hypercholesterolemic children.
Hasanoğlu A; Okur I; Oren AC; Biberoğlu G; Oktar S; Eminoğlu FT; Tümer L
Turk J Pediatr; 2011; 53(5):522-7. PubMed ID: 22272452
[TBL] [Abstract][Full Text] [Related]
29. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
Contacos C; Barter PJ; Vrga L; Sullivan DR
Atherosclerosis; 1998 Nov; 141(1):87-98. PubMed ID: 9863541
[TBL] [Abstract][Full Text] [Related]
30. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia.
Santinga JT; Rosman HS; Rubenfire M; Maciejko JJ; Kobylak L; McGovern ME; Behounek BD
Am J Med; 1994 Jun; 96(6):509-15. PubMed ID: 8017448
[TBL] [Abstract][Full Text] [Related]
32. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
[TBL] [Abstract][Full Text] [Related]
33. Effect of moderate and high-dose simvastatin on asymmetric dimethylarginine-homocysteine metabolic pathways in patients with newly detected severe hypercholesterolemia.
Vladimirova-Kitova LG; Deneva TI; Marinov B
Cardiovasc Ther; 2011 Oct; 29(5):340-8. PubMed ID: 20345493
[TBL] [Abstract][Full Text] [Related]
34. Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study).
Sasaki J; Otonari T; Sawayama Y; Hata S; Oshima Y; Saikawa T; Biro S; Kono S;
J Atheroscler Thromb; 2012; 19(5):485-93. PubMed ID: 22659533
[TBL] [Abstract][Full Text] [Related]
35. Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus.
Pitocco D; Zaccardi F; Di Stasio E; Romitelli F; Martini F; Scaglione GL; Speranza D; Santini S; Zuppi C; Ghirlanda G
Diabetes Res Clin Pract; 2009 Dec; 86(3):173-6. PubMed ID: 19836094
[TBL] [Abstract][Full Text] [Related]
36. High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats.
Landim MB; Dourado PM; Casella-Filho A; Chagas AC; da-Luz PL
Braz J Med Biol Res; 2013 May; 46(5):454-9. PubMed ID: 23681289
[TBL] [Abstract][Full Text] [Related]
37. Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study.
Kietsiriroje N; Leelawattana R
BMC Res Notes; 2015 Jul; 8():294. PubMed ID: 26148680
[TBL] [Abstract][Full Text] [Related]
38. Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II.
Chobanyan-Jürgens K; Fuchs AJ; Tsikas D; Kanzelmeyer N; Das AM; Illsinger S; Vaske B; Jordan J; Lücke T
Amino Acids; 2012 Aug; 43(2):805-11. PubMed ID: 22075968
[TBL] [Abstract][Full Text] [Related]
39. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
40. Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I.
Kasapkara ÇS; Tümer L; Biberoglu G; Kasapkara A; Hasanoğlu A
J Pediatr Endocrinol Metab; 2013; 26(5-6):427-31. PubMed ID: 23412857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
